APA (7th ed.) Citation

Soliman, A. T., Alyafei, F., Alaaraj, N. M., Ahmed, S. M., AlHumaidi, N. S., Hamed, N., . . . Khalil, A. (2025). Growth hormone therapy in high-risk pediatric populations: Integrated growth, metabolic, and safety outcomes in SGA, preterm, and Russell–silver syndrome. Zenodo.

Chicago Style (17th ed.) Citation

Soliman, Ashraf T., Fawzia Alyafei, Nada M. Alaaraj, Shayma M. Ahmed, Noora S. AlHumaidi, Noor Hamed, Ahmed S. Elawwa, and Ahmed Khalil. Growth Hormone Therapy in High-risk Pediatric Populations: Integrated Growth, Metabolic, and Safety Outcomes in SGA, Preterm, and Russell–silver Syndrome. Zenodo, 2025.

MLA (9th ed.) Citation

Soliman, Ashraf T., et al. Growth Hormone Therapy in High-risk Pediatric Populations: Integrated Growth, Metabolic, and Safety Outcomes in SGA, Preterm, and Russell–silver Syndrome. Zenodo, 2025.